Feng Shen

722 total citations
13 papers, 477 citations indexed

About

Feng Shen is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feng Shen has authored 13 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feng Shen's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Liver Disease and Transplantation (2 papers). Feng Shen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Liver Disease and Transplantation (2 papers). Feng Shen collaborates with scholars based in China, Hong Kong and United States. Feng Shen's co-authors include Wan Yee Lau, Xiaofeng Zhang, Jun Li, Yong Xia, Mengchao Wu, Lehua Shi, Guoan Xiang, Hanning Wang, Kai‐Yun Chen and Changquan Ling and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Oncology.

In The Last Decade

Feng Shen

12 papers receiving 470 citations

Peers

Feng Shen

HEPAT

EPIDE

SURGE

Juxian Sun China

Giulia Negrini Italy

Erlei Zhang China

Yong‐Fa Zhang China

Ru-Hai Zou China

Lukas Frick Switzerland

Mariella Di Marco Italy

Lan‐Qing Yao China

Jianxing Zeng China

P. Merle United States

Juxian Sun China

Feng Shen

384 ×1.1

HEPAT

175 ×1.2

EPIDE

161 ×1.3

SURGE

111 ×1.1

94 ×1.3

Citations per year, relative to Feng Shen Feng Shen (= 1×) peers Juxian Sun

Countries citing papers authored by Feng Shen

Since Specialization

Citations

This map shows the geographic impact of Feng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Shen more than expected).

Fields of papers citing papers by Feng Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Shen. The network helps show where Feng Shen may publish in the future.

Co-authorship network of co-authors of Feng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Shen. A scholar is included among the top collaborators of Feng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Shen. Feng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sun, Juxian, Yong Xia, Feng Shen, & Shuqun Cheng. (2025). Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition). HepatoBiliary Surgery and Nutrition. 14(2). 246–266.

Endo, Yutaka, Alfredo Guglielmi, Luca Aldrighetti, et al.. (2024). Upfront surgery for intrahepatic cholangiocarcinoma: Prediction of futility using artificial intelligence. Surgery. 179. 108809–108809. 3 indexed citations

Endo, Yutaka, Muhammad Musaab Munir, Muhammad Muntazir Mehdi Khan, et al.. (2024). Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma. HPB. 26(8). 1040–1050. 3 indexed citations

Wang, Kun, Tianqiang Song, Maohui Chen, et al.. (2023). 169P Conversion response and prognostic factors in HCC patients with macrovascular invasion treated with atezolizumab plus bevacizumab. Annals of Oncology. 34. S1541–S1541. 3 indexed citations

Li, Chao, Zhi-Peng Liu, Li‐Yang Sun, et al.. (2023). Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma. SHILAP Revista de lepidopterología. 1(1). e100008–e100008. 5 indexed citations

Liang, Lei, Chao Li, Yong‐Kang Diao, et al.. (2020). Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology. 13. 3974166557–3974166557. 29 indexed citations

Zhang, Xiaofeng, Jun Li, Feng Shen, & Wan Yee Lau. (2017). Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 33(2). 347–354. 198 indexed citations

Zhai, Xiaofeng, Zhe Chen, Bai Li, et al.. (2013). Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. Journal of Integrative Medicine. 11(2). 90–100. 82 indexed citations

Chen, Kai‐Yun, et al.. (2013). Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial. PLoS ONE. 8(2). e57397–e57397. 45 indexed citations

10.

Shen, Feng, et al.. (2011). Narrow-band UVB combined with Mizolastine in the treatment of chronic idiopathic urticaria. 40(8). 504–506. 1 indexed citations

11.

Zhang, Xiaofeng, Eric C. H. Lai, Xiaoyan Kang, et al.. (2011). Lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein as a Marker of Prognosis and a Monitor of Recurrence of Hepatocellular Carcinoma After Curative Liver Resection. Annals of Surgical Oncology. 18(8). 2218–2223. 20 indexed citations

12.

Xia, Yong, Jun Li, Lehua Shi, et al.. (2010). Adjuvant Therapy With Capecitabine Postpones Recurrence of Hepatocellular Carcinoma After Curative Resection: A Randomized Controlled Trial. Annals of Surgical Oncology. 17(12). 3137–3144. 64 indexed citations

13.

Lai, Eric C. H., et al.. (2009). Enucleation of liver hemangiomas: is there a difference in surgical outcomes for centrally or peripherally located lesions?. The American Journal of Surgery. 198(2). 184–187. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact